A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében.

Translated title of the contribution: Progress in the treatment of gastrointestinal cancers due to introduction of neoadjuvant concept

Péter Horváth Ors, András Papp, Katalin Kalmár, László Cseke, Al Farhat Yousuf, O. Ésik

Research output: Contribution to journalArticle

Abstract

Formerly the treatment of gastrointestinal cancers was exclusively surgical. Though the results were improved by increased radicality, the real progress was achieved by the introduction of multimodal therapy, particularly by the neoadjuvant concept. The basic prerequisite for neoadjuvant treatment is precise staging and risk assessment. According to staging patients can be divided into three categories: (1) Early cancers, confined to the mucosal and submucosal layers, are approached with primary surgery. (2) Systemically metastasized tumors receive merely palliative treatment. (3) Locally advanced cancers are treated by neoadjuvant therapy. Due to neoadjuvant treatment the tumor can be downsized (or downstaged) in some patients. These are the responders benefiting from the therapy, because of the increased RO-resection rate, decreased recurrence rate and improved survival. The non-responders, by contrast have poor prognosis. Neoadjuvant treatment considerably improved the chance for cure for patients with gastrointestinal cancers, thus this method became an evidence based treatment for locally advanced gastrointestinal cancers.

Original languageHungarian
Pages (from-to)333-341
Number of pages9
JournalMagyar sebészet
Volume59
Issue number5
Publication statusPublished - Oct 2006

Fingerprint

Neoadjuvant Therapy
Gastrointestinal Neoplasms
Neoplasms
Therapeutics
Palliative Care
Survival Rate
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Horváth Ors, P., Papp, A., Kalmár, K., Cseke, L., Yousuf, A. F., & Ésik, O. (2006). A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében. Magyar sebészet, 59(5), 333-341.

A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében. / Horváth Ors, Péter; Papp, András; Kalmár, Katalin; Cseke, László; Yousuf, Al Farhat; Ésik, O.

In: Magyar sebészet, Vol. 59, No. 5, 10.2006, p. 333-341.

Research output: Contribution to journalArticle

Horváth Ors, P, Papp, A, Kalmár, K, Cseke, L, Yousuf, AF & Ésik, O 2006, 'A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében.', Magyar sebészet, vol. 59, no. 5, pp. 333-341.
Horváth Ors P, Papp A, Kalmár K, Cseke L, Yousuf AF, Ésik O. A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében. Magyar sebészet. 2006 Oct;59(5):333-341.
Horváth Ors, Péter ; Papp, András ; Kalmár, Katalin ; Cseke, László ; Yousuf, Al Farhat ; Ésik, O. / A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében. In: Magyar sebészet. 2006 ; Vol. 59, No. 5. pp. 333-341.
@article{67c57beced8745bea6f7ec8e125ccb43,
title = "A neoadjuv{\'a}ns kezel{\'e}s eredmenyezte fejlod{\'e}s a gasztrointesztin{\'a}lis daganatok seb{\'e}szet{\'e}ben.",
abstract = "Formerly the treatment of gastrointestinal cancers was exclusively surgical. Though the results were improved by increased radicality, the real progress was achieved by the introduction of multimodal therapy, particularly by the neoadjuvant concept. The basic prerequisite for neoadjuvant treatment is precise staging and risk assessment. According to staging patients can be divided into three categories: (1) Early cancers, confined to the mucosal and submucosal layers, are approached with primary surgery. (2) Systemically metastasized tumors receive merely palliative treatment. (3) Locally advanced cancers are treated by neoadjuvant therapy. Due to neoadjuvant treatment the tumor can be downsized (or downstaged) in some patients. These are the responders benefiting from the therapy, because of the increased RO-resection rate, decreased recurrence rate and improved survival. The non-responders, by contrast have poor prognosis. Neoadjuvant treatment considerably improved the chance for cure for patients with gastrointestinal cancers, thus this method became an evidence based treatment for locally advanced gastrointestinal cancers.",
author = "{Horv{\'a}th Ors}, P{\'e}ter and Andr{\'a}s Papp and Katalin Kalm{\'a}r and L{\'a}szl{\'o} Cseke and Yousuf, {Al Farhat} and O. {\'E}sik",
year = "2006",
month = "10",
language = "Hungarian",
volume = "59",
pages = "333--341",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "5",

}

TY - JOUR

T1 - A neoadjuváns kezelés eredmenyezte fejlodés a gasztrointesztinális daganatok sebészetében.

AU - Horváth Ors, Péter

AU - Papp, András

AU - Kalmár, Katalin

AU - Cseke, László

AU - Yousuf, Al Farhat

AU - Ésik, O.

PY - 2006/10

Y1 - 2006/10

N2 - Formerly the treatment of gastrointestinal cancers was exclusively surgical. Though the results were improved by increased radicality, the real progress was achieved by the introduction of multimodal therapy, particularly by the neoadjuvant concept. The basic prerequisite for neoadjuvant treatment is precise staging and risk assessment. According to staging patients can be divided into three categories: (1) Early cancers, confined to the mucosal and submucosal layers, are approached with primary surgery. (2) Systemically metastasized tumors receive merely palliative treatment. (3) Locally advanced cancers are treated by neoadjuvant therapy. Due to neoadjuvant treatment the tumor can be downsized (or downstaged) in some patients. These are the responders benefiting from the therapy, because of the increased RO-resection rate, decreased recurrence rate and improved survival. The non-responders, by contrast have poor prognosis. Neoadjuvant treatment considerably improved the chance for cure for patients with gastrointestinal cancers, thus this method became an evidence based treatment for locally advanced gastrointestinal cancers.

AB - Formerly the treatment of gastrointestinal cancers was exclusively surgical. Though the results were improved by increased radicality, the real progress was achieved by the introduction of multimodal therapy, particularly by the neoadjuvant concept. The basic prerequisite for neoadjuvant treatment is precise staging and risk assessment. According to staging patients can be divided into three categories: (1) Early cancers, confined to the mucosal and submucosal layers, are approached with primary surgery. (2) Systemically metastasized tumors receive merely palliative treatment. (3) Locally advanced cancers are treated by neoadjuvant therapy. Due to neoadjuvant treatment the tumor can be downsized (or downstaged) in some patients. These are the responders benefiting from the therapy, because of the increased RO-resection rate, decreased recurrence rate and improved survival. The non-responders, by contrast have poor prognosis. Neoadjuvant treatment considerably improved the chance for cure for patients with gastrointestinal cancers, thus this method became an evidence based treatment for locally advanced gastrointestinal cancers.

UR - http://www.scopus.com/inward/record.url?scp=34247848060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247848060&partnerID=8YFLogxK

M3 - Article

C2 - 17201341

AN - SCOPUS:34247848060

VL - 59

SP - 333

EP - 341

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 5

ER -